| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Medicaid | 48 | 2024 | 2808 | 5.130 |
Why?
|
| Reimbursement Mechanisms | 17 | 2023 | 662 | 4.460 |
Why?
|
| Medicare | 64 | 2023 | 6763 | 4.400 |
Why?
|
| Patient Protection and Affordable Care Act | 23 | 2022 | 1200 | 4.100 |
Why?
|
| Quality of Health Care | 59 | 2023 | 4356 | 4.020 |
Why?
|
| Hospitals | 46 | 2024 | 3929 | 3.880 |
Why?
|
| Insurance Coverage | 23 | 2024 | 1939 | 3.670 |
Why?
|
| Reimbursement, Incentive | 17 | 2017 | 543 | 3.020 |
Why?
|
| Hospital Administration | 9 | 2019 | 354 | 2.420 |
Why?
|
| Skilled Nursing Facilities | 8 | 2023 | 397 | 2.340 |
Why?
|
| Economics, Hospital | 10 | 2021 | 212 | 2.220 |
Why?
|
| Quality Indicators, Health Care | 30 | 2014 | 1822 | 2.150 |
Why?
|
| Insurance, Health | 29 | 2022 | 2500 | 2.110 |
Why?
|
| Medically Uninsured | 17 | 2020 | 843 | 2.090 |
Why?
|
| State Health Plans | 11 | 2017 | 219 | 2.090 |
Why?
|
| Managed Care Programs | 16 | 2008 | 938 | 1.990 |
Why?
|
| Health Services Accessibility | 40 | 2024 | 5366 | 1.850 |
Why?
|
| United States | 187 | 2024 | 72238 | 1.840 |
Why?
|
| Health Expenditures | 14 | 2021 | 2354 | 1.840 |
Why?
|
| Subacute Care | 5 | 2021 | 177 | 1.820 |
Why?
|
| Poverty | 22 | 2024 | 2679 | 1.790 |
Why?
|
| Patient Readmission | 16 | 2021 | 3323 | 1.760 |
Why?
|
| Quality Assurance, Health Care | 21 | 2018 | 2179 | 1.740 |
Why?
|
| State Government | 8 | 2020 | 379 | 1.710 |
Why?
|
| Arthroplasty, Replacement | 3 | 2021 | 309 | 1.660 |
Why?
|
| Employment | 6 | 2022 | 1111 | 1.650 |
Why?
|
| Episode of Care | 5 | 2021 | 127 | 1.610 |
Why?
|
| Diagnosis-Related Groups | 14 | 2021 | 450 | 1.500 |
Why?
|
| Eligibility Determination | 6 | 2019 | 419 | 1.320 |
Why?
|
| Group Practice | 5 | 2021 | 151 | 1.260 |
Why?
|
| Health Benefit Plans, Employee | 12 | 2009 | 333 | 1.260 |
Why?
|
| Health Care Reform | 10 | 2016 | 1245 | 1.170 |
Why?
|
| Coronary Artery Bypass | 14 | 2014 | 2274 | 1.170 |
Why?
|
| Physician Incentive Plans | 6 | 2006 | 165 | 1.130 |
Why?
|
| Quality Improvement | 7 | 2024 | 3835 | 1.110 |
Why?
|
| Health Maintenance Organizations | 15 | 2008 | 659 | 1.080 |
Why?
|
| Attitude to Health | 10 | 2020 | 2028 | 1.060 |
Why?
|
| Health Care Costs | 9 | 2020 | 3253 | 1.010 |
Why?
|
| Governing Board | 4 | 2013 | 51 | 1.000 |
Why?
|
| Healthcare Disparities | 10 | 2018 | 3364 | 0.990 |
Why?
|
| Pneumonia | 13 | 2018 | 2139 | 0.980 |
Why?
|
| Health Services for the Aged | 6 | 2011 | 259 | 0.890 |
Why?
|
| Hospital Mortality | 12 | 2013 | 5414 | 0.840 |
Why?
|
| Public Opinion | 3 | 2017 | 481 | 0.820 |
Why?
|
| Acquired Immunodeficiency Syndrome | 14 | 1997 | 2198 | 0.810 |
Why?
|
| Information Services | 7 | 2000 | 235 | 0.750 |
Why?
|
| Physicians | 17 | 2021 | 4583 | 0.720 |
Why?
|
| Total Quality Management | 6 | 2004 | 264 | 0.720 |
Why?
|
| Hospital Costs | 6 | 2018 | 977 | 0.720 |
Why?
|
| Data Collection | 14 | 2019 | 3317 | 0.710 |
Why?
|
| Insurance Carriers | 2 | 2022 | 156 | 0.690 |
Why?
|
| Benchmarking | 9 | 2010 | 1040 | 0.680 |
Why?
|
| Humans | 255 | 2024 | 759098 | 0.680 |
Why?
|
| Arkansas | 5 | 2024 | 59 | 0.670 |
Why?
|
| Insurance, Pharmaceutical Services | 6 | 2011 | 345 | 0.670 |
Why?
|
| Health Status Disparities | 4 | 2020 | 1818 | 0.660 |
Why?
|
| Myocardial Infarction | 20 | 2018 | 11891 | 0.660 |
Why?
|
| Patient Discharge | 11 | 2023 | 3460 | 0.660 |
Why?
|
| Vulnerable Populations | 5 | 2018 | 696 | 0.630 |
Why?
|
| State Medicine | 4 | 2013 | 213 | 0.630 |
Why?
|
| Patient Satisfaction | 12 | 2014 | 3448 | 0.620 |
Why?
|
| Frail Elderly | 2 | 2020 | 746 | 0.580 |
Why?
|
| Efficiency, Organizational | 3 | 2011 | 694 | 0.550 |
Why?
|
| Social Perception | 1 | 2020 | 431 | 0.540 |
Why?
|
| Aged | 93 | 2023 | 168615 | 0.540 |
Why?
|
| Aged, 80 and over | 44 | 2022 | 58864 | 0.530 |
Why?
|
| Health Care Surveys | 15 | 2019 | 2434 | 0.520 |
Why?
|
| Minority Groups | 2 | 2014 | 1198 | 0.510 |
Why?
|
| Health Status | 15 | 2022 | 4079 | 0.510 |
Why?
|
| Fee-for-Service Plans | 6 | 2018 | 705 | 0.500 |
Why?
|
| Politics | 5 | 2017 | 815 | 0.490 |
Why?
|
| Female | 137 | 2024 | 390174 | 0.490 |
Why?
|
| Male | 127 | 2024 | 358602 | 0.480 |
Why?
|
| Private Sector | 4 | 2019 | 398 | 0.480 |
Why?
|
| Hospitalization | 17 | 2023 | 10732 | 0.470 |
Why?
|
| Administrative Personnel | 2 | 2014 | 181 | 0.460 |
Why?
|
| Heart Failure | 15 | 2021 | 11832 | 0.460 |
Why?
|
| Developed Countries | 3 | 2007 | 439 | 0.440 |
Why?
|
| Cost Savings | 5 | 2017 | 921 | 0.440 |
Why?
|
| Budgets | 2 | 2013 | 230 | 0.430 |
Why?
|
| Social Class | 4 | 2008 | 2005 | 0.430 |
Why?
|
| Health Services | 5 | 2015 | 754 | 0.430 |
Why?
|
| Middle Aged | 85 | 2024 | 219628 | 0.430 |
Why?
|
| Costs and Cost Analysis | 17 | 2020 | 1674 | 0.420 |
Why?
|
| Mortality | 4 | 2021 | 2913 | 0.420 |
Why?
|
| Home Care Services | 3 | 2017 | 649 | 0.410 |
Why?
|
| Hospitals, Teaching | 10 | 1998 | 1166 | 0.410 |
Why?
|
| Ambulatory Care | 15 | 1994 | 2775 | 0.410 |
Why?
|
| Adult | 88 | 2024 | 219353 | 0.400 |
Why?
|
| Formularies as Topic | 4 | 2005 | 93 | 0.400 |
Why?
|
| Preventive Health Services | 5 | 2017 | 571 | 0.400 |
Why?
|
| Texas | 3 | 2020 | 401 | 0.400 |
Why?
|
| Coronary Disease | 10 | 2012 | 5989 | 0.400 |
Why?
|
| Social Environment | 1 | 2016 | 1019 | 0.390 |
Why?
|
| Primary Health Care | 7 | 2016 | 4638 | 0.380 |
Why?
|
| Drug Utilization | 5 | 2012 | 1195 | 0.380 |
Why?
|
| Policy | 1 | 2015 | 510 | 0.380 |
Why?
|
| Medical Errors | 7 | 2011 | 1254 | 0.370 |
Why?
|
| Salaries and Fringe Benefits | 4 | 2006 | 256 | 0.370 |
Why?
|
| Capitation Fee | 4 | 2004 | 116 | 0.360 |
Why?
|
| Surgical Procedures, Operative | 5 | 2005 | 1914 | 0.360 |
Why?
|
| Uncertainty | 2 | 2011 | 754 | 0.350 |
Why?
|
| Patient Admission | 3 | 2011 | 1383 | 0.350 |
Why?
|
| Government Regulation | 2 | 2016 | 526 | 0.340 |
Why?
|
| Residence Characteristics | 2 | 2017 | 2035 | 0.340 |
Why?
|
| Logistic Models | 17 | 2018 | 13309 | 0.340 |
Why?
|
| Risk Adjustment | 5 | 2014 | 601 | 0.330 |
Why?
|
| Thoracic Surgery | 3 | 2013 | 722 | 0.330 |
Why?
|
| California | 8 | 2014 | 1403 | 0.320 |
Why?
|
| Program Evaluation | 2 | 2017 | 2487 | 0.320 |
Why?
|
| Diagnostic Tests, Routine | 7 | 2008 | 784 | 0.320 |
Why?
|
| Length of Stay | 17 | 2023 | 6452 | 0.320 |
Why?
|
| Independent Practice Associations | 3 | 2006 | 21 | 0.320 |
Why?
|
| Cost-Benefit Analysis | 11 | 2020 | 5499 | 0.320 |
Why?
|
| Drug Prescriptions | 5 | 2005 | 1673 | 0.310 |
Why?
|
| Case Management | 2 | 2014 | 272 | 0.310 |
Why?
|
| Drug Costs | 6 | 2012 | 1183 | 0.310 |
Why?
|
| Group Purchasing | 1 | 2007 | 9 | 0.310 |
Why?
|
| Health Policy | 8 | 2022 | 2674 | 0.310 |
Why?
|
| Delivery of Health Care | 8 | 2023 | 5310 | 0.300 |
Why?
|
| Kidney Failure, Chronic | 5 | 2008 | 2438 | 0.300 |
Why?
|
| Fees and Charges | 6 | 2016 | 191 | 0.300 |
Why?
|
| Angioplasty, Balloon, Coronary | 5 | 2003 | 1880 | 0.290 |
Why?
|
| Massachusetts | 28 | 2014 | 8788 | 0.290 |
Why?
|
| Socioeconomic Factors | 20 | 2019 | 7790 | 0.290 |
Why?
|
| Economics, Medical | 1 | 2007 | 112 | 0.290 |
Why?
|
| Referral and Consultation | 8 | 2013 | 3598 | 0.280 |
Why?
|
| Marketing of Health Services | 1 | 2007 | 150 | 0.270 |
Why?
|
| Fees, Medical | 4 | 1992 | 111 | 0.270 |
Why?
|
| Iatrogenic Disease | 1 | 2009 | 537 | 0.270 |
Why?
|
| Regression Analysis | 11 | 2021 | 6358 | 0.270 |
Why?
|
| Hospital Bed Capacity | 4 | 2008 | 210 | 0.270 |
Why?
|
| Attitude of Health Personnel | 12 | 2013 | 3864 | 0.270 |
Why?
|
| Competitive Medical Plans | 1 | 2005 | 26 | 0.260 |
Why?
|
| Kentucky | 2 | 2016 | 84 | 0.260 |
Why?
|
| Technology, High-Cost | 2 | 2004 | 32 | 0.260 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2013 | 933 | 0.250 |
Why?
|
| Interviews as Topic | 13 | 2013 | 2649 | 0.250 |
Why?
|
| Internal Medicine | 4 | 2009 | 1045 | 0.250 |
Why?
|
| Lovastatin | 2 | 1996 | 116 | 0.250 |
Why?
|
| Health Services Needs and Demand | 4 | 2011 | 1394 | 0.250 |
Why?
|
| Retrospective Studies | 24 | 2023 | 80125 | 0.250 |
Why?
|
| Health Services Research | 11 | 2005 | 1809 | 0.240 |
Why?
|
| Hospitalists | 1 | 2009 | 295 | 0.240 |
Why?
|
| Surgery Department, Hospital | 1 | 2006 | 176 | 0.240 |
Why?
|
| Niacin | 2 | 1996 | 119 | 0.240 |
Why?
|
| Income | 7 | 2020 | 1876 | 0.240 |
Why?
|
| Sampling Studies | 4 | 2009 | 613 | 0.240 |
Why?
|
| Kidney Transplantation | 5 | 2008 | 4163 | 0.230 |
Why?
|
| Medication Adherence | 2 | 2016 | 2161 | 0.230 |
Why?
|
| Guideline Adherence | 4 | 2021 | 2283 | 0.230 |
Why?
|
| Public Sector | 1 | 2005 | 265 | 0.230 |
Why?
|
| Young Adult | 14 | 2024 | 58477 | 0.230 |
Why?
|
| Patient Selection | 6 | 2021 | 4268 | 0.220 |
Why?
|
| Safety Management | 2 | 2008 | 760 | 0.220 |
Why?
|
| Specialization | 2 | 2007 | 780 | 0.210 |
Why?
|
| Provider-Sponsored Organizations | 1 | 2002 | 12 | 0.210 |
Why?
|
| Patient Participation | 7 | 2014 | 1437 | 0.210 |
Why?
|
| Disclosure | 3 | 2014 | 738 | 0.210 |
Why?
|
| Diffusion of Innovation | 1 | 2007 | 730 | 0.210 |
Why?
|
| Hypercholesterolemia | 4 | 2000 | 1155 | 0.210 |
Why?
|
| Tamoxifen | 1 | 2007 | 962 | 0.210 |
Why?
|
| Physicians, Family | 1 | 2004 | 350 | 0.200 |
Why?
|
| Cost Control | 8 | 2024 | 630 | 0.200 |
Why?
|
| New York | 4 | 2013 | 874 | 0.200 |
Why?
|
| Diagnostic Services | 3 | 1987 | 34 | 0.200 |
Why?
|
| Patients | 6 | 2013 | 907 | 0.200 |
Why?
|
| Chi-Square Distribution | 6 | 2011 | 3469 | 0.190 |
Why?
|
| Health Facilities, Proprietary | 1 | 2001 | 37 | 0.190 |
Why?
|
| Societies, Medical | 2 | 2004 | 3890 | 0.190 |
Why?
|
| Medicare Part B | 2 | 1993 | 116 | 0.190 |
Why?
|
| Health Facility Administrators | 1 | 2021 | 32 | 0.190 |
Why?
|
| Quality of Life | 9 | 2022 | 13285 | 0.190 |
Why?
|
| Mass Screening | 4 | 2016 | 5419 | 0.190 |
Why?
|
| Depressive Disorder | 2 | 2011 | 3728 | 0.180 |
Why?
|
| Organizations, Nonprofit | 1 | 2001 | 105 | 0.180 |
Why?
|
| United States Public Health Service | 1 | 2020 | 32 | 0.180 |
Why?
|
| Coronary Vessels | 1 | 2012 | 3110 | 0.180 |
Why?
|
| Physician-Patient Relations | 7 | 2008 | 3235 | 0.180 |
Why?
|
| Geography | 2 | 2014 | 661 | 0.170 |
Why?
|
| Sex | 1 | 1999 | 52 | 0.170 |
Why?
|
| Legislation, Hospital | 1 | 2019 | 11 | 0.170 |
Why?
|
| Physician's Role | 3 | 1996 | 920 | 0.170 |
Why?
|
| Colorectal Neoplasms | 3 | 2008 | 6853 | 0.170 |
Why?
|
| Health Services Misuse | 1 | 2001 | 245 | 0.170 |
Why?
|
| Patient Compliance | 2 | 2007 | 2689 | 0.170 |
Why?
|
| Drug Industry | 2 | 2004 | 789 | 0.160 |
Why?
|
| Postal Service | 1 | 2019 | 94 | 0.160 |
Why?
|
| Kansas | 1 | 2018 | 39 | 0.160 |
Why?
|
| Accreditation | 1 | 2002 | 474 | 0.160 |
Why?
|
| Health Care Sector | 3 | 2013 | 196 | 0.160 |
Why?
|
| Indiana | 1 | 2018 | 91 | 0.160 |
Why?
|
| Information Systems | 3 | 2003 | 398 | 0.150 |
Why?
|
| Medical Audit | 3 | 2008 | 451 | 0.150 |
Why?
|
| Mental Disorders | 3 | 2014 | 6788 | 0.150 |
Why?
|
| Organizational Innovation | 1 | 2001 | 535 | 0.150 |
Why?
|
| Patient-Centered Care | 2 | 2008 | 1414 | 0.150 |
Why?
|
| Prenatal Care | 3 | 1994 | 1125 | 0.150 |
Why?
|
| Pulmonary Emphysema | 1 | 2003 | 687 | 0.150 |
Why?
|
| Ohio | 1 | 2018 | 329 | 0.150 |
Why?
|
| Information Dissemination | 1 | 2006 | 1132 | 0.150 |
Why?
|
| Adolescent | 29 | 2019 | 87551 | 0.150 |
Why?
|
| Odds Ratio | 11 | 2009 | 9712 | 0.150 |
Why?
|
| Medical Records | 5 | 2008 | 1405 | 0.140 |
Why?
|
| Cohort Studies | 14 | 2023 | 41266 | 0.140 |
Why?
|
| Survivors | 1 | 2007 | 2355 | 0.140 |
Why?
|
| Medicare Part C | 1 | 2002 | 316 | 0.140 |
Why?
|
| Cross-Sectional Studies | 10 | 2021 | 25853 | 0.140 |
Why?
|
| Professional Practice | 2 | 2017 | 313 | 0.140 |
Why?
|
| Workload | 1 | 2002 | 842 | 0.140 |
Why?
|
| Cardiology Service, Hospital | 1 | 1998 | 242 | 0.130 |
Why?
|
| Pneumonectomy | 1 | 2003 | 1109 | 0.130 |
Why?
|
| Telephone | 2 | 2019 | 622 | 0.130 |
Why?
|
| Coronary Angiography | 6 | 1997 | 4559 | 0.130 |
Why?
|
| Boston | 13 | 1997 | 9274 | 0.130 |
Why?
|
| Therapeutics | 1 | 1996 | 114 | 0.130 |
Why?
|
| Comorbidity | 5 | 2020 | 10550 | 0.130 |
Why?
|
| Diagnostic Techniques and Procedures | 2 | 2010 | 220 | 0.130 |
Why?
|
| Statistics, Nonparametric | 2 | 2018 | 2852 | 0.130 |
Why?
|
| Models, Economic | 2 | 2010 | 717 | 0.130 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2017 | 225 | 0.130 |
Why?
|
| Life Support Care | 2 | 1995 | 222 | 0.130 |
Why?
|
| Activities of Daily Living | 10 | 2022 | 2413 | 0.120 |
Why?
|
| Taxes | 1 | 2017 | 222 | 0.120 |
Why?
|
| Demography | 6 | 2008 | 1648 | 0.120 |
Why?
|
| Birth Certificates | 1 | 1994 | 70 | 0.120 |
Why?
|
| Indians, North American | 1 | 2018 | 352 | 0.120 |
Why?
|
| Cerebrovascular Disorders | 3 | 1998 | 1498 | 0.120 |
Why?
|
| Insurance, Hospitalization | 2 | 1991 | 30 | 0.120 |
Why?
|
| Sex Factors | 11 | 2018 | 10515 | 0.120 |
Why?
|
| Severity of Illness Index | 11 | 1999 | 15815 | 0.110 |
Why?
|
| Insurance Claim Reporting | 1 | 1994 | 165 | 0.110 |
Why?
|
| Influenza Vaccines | 1 | 2001 | 771 | 0.110 |
Why?
|
| Decision Making | 6 | 2012 | 3917 | 0.110 |
Why?
|
| Breast Neoplasms | 7 | 2011 | 21019 | 0.110 |
Why?
|
| District of Columbia | 1 | 2014 | 160 | 0.110 |
Why?
|
| Linear Models | 4 | 2011 | 5876 | 0.110 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 1 | 2014 | 303 | 0.110 |
Why?
|
| Quality-Adjusted Life Years | 2 | 2003 | 1719 | 0.110 |
Why?
|
| Florida | 2 | 2012 | 427 | 0.110 |
Why?
|
| Pandemics | 6 | 2023 | 8604 | 0.110 |
Why?
|
| Pharmaceutical Preparations | 1 | 2002 | 1093 | 0.110 |
Why?
|
| Infection Control | 1 | 2021 | 982 | 0.110 |
Why?
|
| Connecticut | 1 | 2014 | 364 | 0.110 |
Why?
|
| Fee Schedules | 3 | 2004 | 85 | 0.110 |
Why?
|
| Medical Record Linkage | 1 | 1994 | 289 | 0.110 |
Why?
|
| Health Status Indicators | 5 | 2000 | 968 | 0.110 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 1998 | 3960 | 0.110 |
Why?
|
| Maternal Welfare | 1 | 1993 | 110 | 0.110 |
Why?
|
| Health Care Coalitions | 2 | 2007 | 36 | 0.110 |
Why?
|
| Pennsylvania | 3 | 1999 | 615 | 0.100 |
Why?
|
| Hospitals, Proprietary | 2 | 2009 | 39 | 0.100 |
Why?
|
| Safety | 2 | 2011 | 1149 | 0.100 |
Why?
|
| Lower Extremity | 1 | 2020 | 1195 | 0.100 |
Why?
|
| Medical Oncology | 1 | 2004 | 2309 | 0.100 |
Why?
|
| Medical Assistance | 1 | 1993 | 107 | 0.100 |
Why?
|
| Health Surveys | 3 | 1992 | 4059 | 0.100 |
Why?
|
| Economic Competition | 3 | 2005 | 218 | 0.100 |
Why?
|
| Emergency Service, Hospital | 3 | 2018 | 7788 | 0.100 |
Why?
|
| Insurance, Physician Services | 1 | 1991 | 23 | 0.100 |
Why?
|
| Random Allocation | 4 | 2003 | 2393 | 0.100 |
Why?
|
| Forecasting | 3 | 2014 | 2928 | 0.100 |
Why?
|
| Geriatric Assessment | 4 | 1993 | 1404 | 0.100 |
Why?
|
| Advance Directives | 1 | 1993 | 248 | 0.100 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2004 | 3152 | 0.090 |
Why?
|
| Supreme Court Decisions | 1 | 2013 | 133 | 0.090 |
Why?
|
| Analysis of Variance | 2 | 2011 | 6239 | 0.090 |
Why?
|
| Cost Sharing | 2 | 2005 | 408 | 0.090 |
Why?
|
| Resuscitation | 1 | 1995 | 662 | 0.090 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2013 | 3617 | 0.090 |
Why?
|
| Self Disclosure | 1 | 2011 | 250 | 0.090 |
Why?
|
| Censuses | 1 | 2011 | 201 | 0.090 |
Why?
|
| Clinical Competence | 1 | 2006 | 4775 | 0.090 |
Why?
|
| Utilization Review | 3 | 2001 | 383 | 0.090 |
Why?
|
| Age Distribution | 1 | 2016 | 2891 | 0.090 |
Why?
|
| Disabled Persons | 2 | 2018 | 1226 | 0.090 |
Why?
|
| Ownership | 2 | 2004 | 335 | 0.090 |
Why?
|
| Risk Factors | 13 | 2017 | 74167 | 0.090 |
Why?
|
| Communication Barriers | 1 | 1993 | 412 | 0.090 |
Why?
|
| Adrenergic beta-Antagonists | 3 | 2007 | 1253 | 0.090 |
Why?
|
| Hypertension | 8 | 2000 | 8582 | 0.090 |
Why?
|
| Disease Management | 2 | 2016 | 2495 | 0.080 |
Why?
|
| Private Practice | 3 | 1986 | 153 | 0.080 |
Why?
|
| Rhode Island | 4 | 1993 | 350 | 0.080 |
Why?
|
| Medically Underserved Area | 1 | 2011 | 258 | 0.080 |
Why?
|
| Exercise Test | 1 | 1997 | 2124 | 0.080 |
Why?
|
| Vaccination | 1 | 2001 | 3354 | 0.080 |
Why?
|
| Dementia | 1 | 2023 | 2634 | 0.080 |
Why?
|
| Myocardial Revascularization | 1 | 1993 | 841 | 0.080 |
Why?
|
| Mandatory Programs | 1 | 2009 | 86 | 0.080 |
Why?
|
| Health Resources | 3 | 1990 | 927 | 0.080 |
Why?
|
| Confidence Intervals | 2 | 2009 | 2932 | 0.080 |
Why?
|
| Anticholesteremic Agents | 1 | 1996 | 987 | 0.080 |
Why?
|
| Prospective Payment System | 2 | 1991 | 136 | 0.080 |
Why?
|
| AIDS-Related Complex | 1 | 1988 | 107 | 0.080 |
Why?
|
| Ticlopidine | 1 | 1994 | 895 | 0.080 |
Why?
|
| Substance Abuse, Intravenous | 1 | 1993 | 529 | 0.080 |
Why?
|
| Survival Analysis | 5 | 2007 | 10181 | 0.080 |
Why?
|
| Models, Psychological | 1 | 1993 | 826 | 0.080 |
Why?
|
| Angiography | 2 | 1991 | 1608 | 0.080 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2019 | 1400 | 0.080 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2019 | 1361 | 0.080 |
Why?
|
| Cholestyramine Resin | 1 | 1987 | 25 | 0.080 |
Why?
|
| Risk | 4 | 2017 | 9622 | 0.080 |
Why?
|
| Multivariate Analysis | 5 | 2009 | 12152 | 0.080 |
Why?
|
| Cholesterol | 3 | 1990 | 2922 | 0.080 |
Why?
|
| Time Factors | 9 | 2017 | 40083 | 0.080 |
Why?
|
| Epidemiologic Methods | 1 | 1992 | 1341 | 0.070 |
Why?
|
| Education, Medical | 5 | 2007 | 1726 | 0.070 |
Why?
|
| Occult Blood | 1 | 2008 | 197 | 0.070 |
Why?
|
| Treatment Outcome | 7 | 2012 | 64867 | 0.070 |
Why?
|
| Program Development | 1 | 2013 | 1295 | 0.070 |
Why?
|
| Washington | 2 | 2005 | 312 | 0.070 |
Why?
|
| Physician Executives | 1 | 2008 | 133 | 0.070 |
Why?
|
| Statistics as Topic | 2 | 2011 | 2364 | 0.070 |
Why?
|
| Decision Making, Organizational | 1 | 2007 | 136 | 0.070 |
Why?
|
| Probability | 2 | 2009 | 2474 | 0.070 |
Why?
|
| Internship and Residency | 2 | 2002 | 5860 | 0.070 |
Why?
|
| Case-Control Studies | 3 | 2021 | 21992 | 0.070 |
Why?
|
| Internet | 1 | 2019 | 3073 | 0.070 |
Why?
|
| Cardiology | 2 | 2006 | 1720 | 0.070 |
Why?
|
| Contracts | 1 | 2006 | 59 | 0.070 |
Why?
|
| Evidence-Based Medicine | 4 | 2008 | 3694 | 0.070 |
Why?
|
| Psychotropic Drugs | 1 | 2012 | 882 | 0.070 |
Why?
|
| Prescription Fees | 2 | 2005 | 151 | 0.070 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 2009 | 488 | 0.070 |
Why?
|
| Health Priorities | 2 | 2006 | 372 | 0.070 |
Why?
|
| Hospital Units | 1 | 1987 | 138 | 0.070 |
Why?
|
| Radiography, Thoracic | 4 | 1986 | 1293 | 0.070 |
Why?
|
| Geriatrics | 2 | 1989 | 385 | 0.070 |
Why?
|
| Consensus Development Conferences as Topic | 1 | 2006 | 169 | 0.060 |
Why?
|
| Nursing Staff, Hospital | 1 | 2009 | 344 | 0.060 |
Why?
|
| Hospitals, Public | 3 | 2011 | 201 | 0.060 |
Why?
|
| Oregon | 1 | 2005 | 148 | 0.060 |
Why?
|
| Likelihood Functions | 3 | 2011 | 988 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 1 | 2003 | 7460 | 0.060 |
Why?
|
| Public Health Informatics | 1 | 2006 | 109 | 0.060 |
Why?
|
| Guidelines as Topic | 2 | 2002 | 1395 | 0.060 |
Why?
|
| Hospitals, General | 1 | 2009 | 795 | 0.060 |
Why?
|
| Models, Organizational | 1 | 2008 | 546 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 1 | 2022 | 9131 | 0.060 |
Why?
|
| Age Factors | 9 | 2018 | 18391 | 0.060 |
Why?
|
| Hospital Administrators | 1 | 2005 | 57 | 0.060 |
Why?
|
| Financial Management, Hospital | 1 | 1985 | 69 | 0.060 |
Why?
|
| Angioplasty, Balloon | 1 | 1989 | 599 | 0.060 |
Why?
|
| Cesarean Section | 1 | 1993 | 1387 | 0.060 |
Why?
|
| Maryland | 3 | 1999 | 274 | 0.060 |
Why?
|
| Child | 11 | 2023 | 79604 | 0.060 |
Why?
|
| Chronic Disease | 4 | 2016 | 9245 | 0.060 |
Why?
|
| Survival Rate | 4 | 2004 | 12793 | 0.060 |
Why?
|
| New Hampshire | 1 | 2004 | 173 | 0.060 |
Why?
|
| Mandatory Reporting | 1 | 2005 | 125 | 0.060 |
Why?
|
| Career Mobility | 1 | 2006 | 256 | 0.060 |
Why?
|
| Acute Disease | 1 | 2014 | 7247 | 0.060 |
Why?
|
| Family Practice | 1 | 2006 | 510 | 0.060 |
Why?
|
| Medication Errors | 1 | 2009 | 781 | 0.060 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 2 | 2012 | 3693 | 0.050 |
Why?
|
| Pneumococcal Vaccines | 1 | 2007 | 397 | 0.050 |
Why?
|
| Financial Management | 1 | 1985 | 161 | 0.050 |
Why?
|
| Databases as Topic | 1 | 2005 | 474 | 0.050 |
Why?
|
| Cross Infection | 2 | 2009 | 1434 | 0.050 |
Why?
|
| Patient Care | 1 | 2009 | 624 | 0.050 |
Why?
|
| Qualitative Research | 1 | 2013 | 2939 | 0.050 |
Why?
|
| Behavior | 1 | 1986 | 539 | 0.050 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 2 | 2007 | 1520 | 0.050 |
Why?
|
| Personnel Staffing and Scheduling | 2 | 2002 | 498 | 0.050 |
Why?
|
| Medical Order Entry Systems | 1 | 2008 | 522 | 0.050 |
Why?
|
| Prejudice | 2 | 2001 | 562 | 0.050 |
Why?
|
| Continuity of Patient Care | 1 | 2010 | 1060 | 0.050 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2004 | 364 | 0.050 |
Why?
|
| Cancer Care Facilities | 1 | 2006 | 424 | 0.050 |
Why?
|
| Social Support | 2 | 2008 | 2141 | 0.050 |
Why?
|
| Organizations | 2 | 2002 | 171 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3088 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3208 | 0.050 |
Why?
|
| Contract Services | 1 | 2002 | 89 | 0.050 |
Why?
|
| Mental Health Services | 2 | 2011 | 1708 | 0.050 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2007 | 577 | 0.050 |
Why?
|
| Follow-Up Studies | 3 | 2019 | 39213 | 0.050 |
Why?
|
| Commerce | 1 | 2007 | 604 | 0.050 |
Why?
|
| Combined Modality Therapy | 1 | 2014 | 8548 | 0.050 |
Why?
|
| Zidovudine | 2 | 1994 | 624 | 0.050 |
Why?
|
| Blood Glucose | 1 | 2016 | 6366 | 0.050 |
Why?
|
| Pregnancy Outcome | 1 | 1993 | 2901 | 0.050 |
Why?
|
| Aspirin | 3 | 2007 | 3359 | 0.050 |
Why?
|
| Computer Systems | 2 | 1996 | 471 | 0.050 |
Why?
|
| Databases, Factual | 5 | 2021 | 8001 | 0.050 |
Why?
|
| Organizational Affiliation | 1 | 2001 | 34 | 0.050 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2004 | 488 | 0.050 |
Why?
|
| United States Agency for Healthcare Research and Quality | 2 | 2000 | 87 | 0.050 |
Why?
|
| Substance-Related Disorders | 3 | 2014 | 4358 | 0.050 |
Why?
|
| Clinical Laboratory Techniques | 2 | 1984 | 749 | 0.050 |
Why?
|
| Education, Medical, Graduate | 2 | 1990 | 2352 | 0.050 |
Why?
|
| Occupations | 3 | 1990 | 513 | 0.050 |
Why?
|
| Europe | 1 | 2008 | 3427 | 0.050 |
Why?
|
| Financing, Personal | 1 | 2004 | 309 | 0.050 |
Why?
|
| Child, Preschool | 6 | 2012 | 41932 | 0.050 |
Why?
|
| Predictive Value of Tests | 3 | 2009 | 15262 | 0.050 |
Why?
|
| Electrocardiography | 5 | 1986 | 6400 | 0.050 |
Why?
|
| Personality | 1 | 1984 | 552 | 0.050 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2002 | 192 | 0.050 |
Why?
|
| Empirical Research | 1 | 2001 | 120 | 0.050 |
Why?
|
| Neoplasms | 3 | 2004 | 22023 | 0.050 |
Why?
|
| Radiotherapy | 1 | 2007 | 1503 | 0.050 |
Why?
|
| Diabetes Mellitus | 3 | 2016 | 5875 | 0.050 |
Why?
|
| Risk-Taking | 2 | 1997 | 999 | 0.040 |
Why?
|
| Nephrology | 1 | 2004 | 240 | 0.040 |
Why?
|
| Risk Assessment | 4 | 2022 | 24049 | 0.040 |
Why?
|
| Colonoscopy | 1 | 2008 | 1388 | 0.040 |
Why?
|
| England | 4 | 2013 | 525 | 0.040 |
Why?
|
| Organizational Policy | 1 | 2002 | 429 | 0.040 |
Why?
|
| Confidentiality | 1 | 2004 | 610 | 0.040 |
Why?
|
| Drug Therapy | 1 | 2003 | 504 | 0.040 |
Why?
|
| Critical Care | 2 | 2008 | 2692 | 0.040 |
Why?
|
| Incidence | 5 | 2009 | 21344 | 0.040 |
Why?
|
| Consumer Advocacy | 1 | 2000 | 81 | 0.040 |
Why?
|
| Illinois | 1 | 1999 | 118 | 0.040 |
Why?
|
| Risk Sharing, Financial | 1 | 1999 | 47 | 0.040 |
Why?
|
| Models, Theoretical | 1 | 2011 | 3556 | 0.040 |
Why?
|
| Algorithms | 2 | 2003 | 13951 | 0.040 |
Why?
|
| Mastectomy | 1 | 2008 | 1832 | 0.040 |
Why?
|
| Medicine | 1 | 2007 | 943 | 0.040 |
Why?
|
| Life Expectancy | 3 | 1994 | 1248 | 0.040 |
Why?
|
| Hawaii | 1 | 2018 | 101 | 0.040 |
Why?
|
| Infant, Newborn | 5 | 2004 | 26099 | 0.040 |
Why?
|
| Internationality | 1 | 2004 | 1003 | 0.040 |
Why?
|
| Hospitals, Community | 2 | 1991 | 367 | 0.040 |
Why?
|
| Neoplasm Staging | 3 | 2010 | 11125 | 0.040 |
Why?
|
| Primary Prevention | 1 | 1986 | 1203 | 0.040 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2003 | 910 | 0.040 |
Why?
|
| Consumer Organizations | 1 | 1997 | 10 | 0.040 |
Why?
|
| Joint Commission on Accreditation of Healthcare Organizations | 1 | 1998 | 92 | 0.040 |
Why?
|
| Feedback | 1 | 2002 | 791 | 0.040 |
Why?
|
| Planning Techniques | 1 | 1998 | 81 | 0.040 |
Why?
|
| Mammaplasty | 1 | 2008 | 1234 | 0.040 |
Why?
|
| Evaluation Studies as Topic | 3 | 1995 | 1631 | 0.040 |
Why?
|
| Women's Health Services | 1 | 2017 | 89 | 0.030 |
Why?
|
| Resuscitation Orders | 1 | 1999 | 270 | 0.030 |
Why?
|
| Reproducibility of Results | 4 | 2011 | 20027 | 0.030 |
Why?
|
| Schizophrenia | 1 | 2015 | 6914 | 0.030 |
Why?
|
| Body Weight | 1 | 1987 | 4606 | 0.030 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2007 | 2128 | 0.030 |
Why?
|
| Certification | 1 | 1999 | 423 | 0.030 |
Why?
|
| Publications | 1 | 1998 | 193 | 0.030 |
Why?
|
| Postoperative Complications | 3 | 2009 | 15662 | 0.030 |
Why?
|
| Oxygen | 1 | 2007 | 4188 | 0.030 |
Why?
|
| Gemfibrozil | 1 | 1995 | 30 | 0.030 |
Why?
|
| Longitudinal Studies | 4 | 2018 | 14439 | 0.030 |
Why?
|
| Lipoprotein(a) | 1 | 2000 | 496 | 0.030 |
Why?
|
| Renal Dialysis | 2 | 2004 | 1758 | 0.030 |
Why?
|
| Cerebral Infarction | 1 | 2000 | 982 | 0.030 |
Why?
|
| Affect | 2 | 1993 | 1479 | 0.030 |
Why?
|
| Asthma | 1 | 1994 | 6159 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 1984 | 1798 | 0.030 |
Why?
|
| Prescription Drugs | 1 | 2022 | 630 | 0.030 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2004 | 2282 | 0.030 |
Why?
|
| Blood Cell Count | 2 | 1986 | 398 | 0.030 |
Why?
|
| Medical Indigency | 2 | 1993 | 63 | 0.030 |
Why?
|
| Prevalence | 3 | 2008 | 15639 | 0.030 |
Why?
|
| Delivery Rooms | 1 | 1994 | 38 | 0.030 |
Why?
|
| Government | 1 | 1995 | 160 | 0.030 |
Why?
|
| Infant | 5 | 2004 | 35940 | 0.030 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2007 | 3193 | 0.030 |
Why?
|
| Urine | 2 | 1986 | 363 | 0.030 |
Why?
|
| Drug Therapy, Combination | 2 | 2012 | 6490 | 0.030 |
Why?
|
| Pregnancy | 5 | 2000 | 29650 | 0.030 |
Why?
|
| Clinical Governance | 1 | 2013 | 7 | 0.030 |
Why?
|
| Prospective Studies | 5 | 2007 | 54190 | 0.030 |
Why?
|
| United States Food and Drug Administration | 1 | 2002 | 1676 | 0.030 |
Why?
|
| Academic Medical Centers | 2 | 1994 | 2750 | 0.030 |
Why?
|
| Drug Utilization Review | 2 | 2005 | 251 | 0.030 |
Why?
|
| Medicare Part A | 1 | 1993 | 40 | 0.030 |
Why?
|
| Prostatectomy | 1 | 2002 | 1943 | 0.030 |
Why?
|
| New Jersey | 1 | 1993 | 291 | 0.030 |
Why?
|
| Scotland | 1 | 2013 | 143 | 0.030 |
Why?
|
| Homosexuality | 1 | 1993 | 261 | 0.030 |
Why?
|
| Diabetic Retinopathy | 1 | 2002 | 1268 | 0.030 |
Why?
|
| Medical Informatics | 1 | 1999 | 732 | 0.030 |
Why?
|
| MEDLINE | 1 | 1992 | 119 | 0.020 |
Why?
|
| Blast Injuries | 1 | 1995 | 322 | 0.020 |
Why?
|
| Dental Care | 1 | 1994 | 278 | 0.020 |
Why?
|
| Financing, Government | 1 | 1995 | 472 | 0.020 |
Why?
|
| General Surgery | 2 | 2002 | 1680 | 0.020 |
Why?
|
| Tachycardia, Ventricular | 1 | 2000 | 1293 | 0.020 |
Why?
|
| Thyroid Function Tests | 1 | 1991 | 290 | 0.020 |
Why?
|
| Los Angeles | 1 | 2011 | 242 | 0.020 |
Why?
|
| Insurance Claim Review | 1 | 1995 | 737 | 0.020 |
Why?
|
| Factor Analysis, Statistical | 1 | 1993 | 998 | 0.020 |
Why?
|
| Minnesota | 1 | 1990 | 340 | 0.020 |
Why?
|
| Public Health | 1 | 2023 | 2656 | 0.020 |
Why?
|
| Anemia, Sickle Cell | 1 | 1998 | 1055 | 0.020 |
Why?
|
| Research Design | 3 | 2003 | 6165 | 0.020 |
Why?
|
| Heptanoic Acids | 1 | 1991 | 347 | 0.020 |
Why?
|
| Ancillary Services, Hospital | 1 | 1989 | 23 | 0.020 |
Why?
|
| Ethics, Medical | 1 | 1995 | 786 | 0.020 |
Why?
|
| Terminal Care | 3 | 1999 | 1758 | 0.020 |
Why?
|
| Choice Behavior | 1 | 1995 | 817 | 0.020 |
Why?
|
| Drugs, Generic | 2 | 2005 | 447 | 0.020 |
Why?
|
| Diet | 1 | 1987 | 8001 | 0.020 |
Why?
|
| Neutropenia | 1 | 1994 | 885 | 0.020 |
Why?
|
| Malpractice | 1 | 1993 | 554 | 0.020 |
Why?
|
| Hospital Bed Capacity, 500 and over | 1 | 1988 | 114 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2007 | 7379 | 0.020 |
Why?
|
| Ischemic Attack, Transient | 1 | 1994 | 899 | 0.020 |
Why?
|
| Collagen Diseases | 1 | 1988 | 39 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 1999 | 5192 | 0.020 |
Why?
|
| Thyroid Diseases | 1 | 1991 | 387 | 0.020 |
Why?
|
| Rate Setting and Review | 1 | 1988 | 41 | 0.020 |
Why?
|
| Receptors, LDL | 1 | 1990 | 491 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 1998 | 2309 | 0.020 |
Why?
|
| Brain Ischemia | 2 | 1998 | 3128 | 0.020 |
Why?
|
| Registries | 2 | 1994 | 8435 | 0.020 |
Why?
|
| Environmental Exposure | 1 | 2022 | 4389 | 0.020 |
Why?
|
| ROC Curve | 1 | 1995 | 3569 | 0.020 |
Why?
|
| Resource Allocation | 1 | 1989 | 346 | 0.020 |
Why?
|
| Meta-Analysis as Topic | 1 | 1992 | 1374 | 0.020 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 1994 | 1132 | 0.020 |
Why?
|
| Catheter Ablation | 1 | 2000 | 2749 | 0.020 |
Why?
|
| Biphenyl Compounds | 1 | 1991 | 987 | 0.020 |
Why?
|
| Causality | 1 | 1993 | 1240 | 0.020 |
Why?
|
| Hospitals, University | 1 | 1988 | 568 | 0.020 |
Why?
|
| Office Visits | 2 | 1988 | 596 | 0.020 |
Why?
|
| Informed Consent | 1 | 1992 | 1007 | 0.020 |
Why?
|
| International Agencies | 1 | 2006 | 244 | 0.020 |
Why?
|
| Hyperlipidemias | 1 | 1990 | 782 | 0.020 |
Why?
|
| Practice Management, Medical | 1 | 1987 | 191 | 0.020 |
Why?
|
| Social Behavior | 2 | 1989 | 1130 | 0.020 |
Why?
|
| Infectious Mononucleosis | 1 | 1986 | 133 | 0.020 |
Why?
|
| Capital Expenditures | 1 | 1985 | 28 | 0.020 |
Why?
|
| Cholesterol, LDL | 1 | 1995 | 2417 | 0.020 |
Why?
|
| Education | 1 | 1988 | 534 | 0.020 |
Why?
|
| Models, Statistical | 2 | 1991 | 5067 | 0.020 |
Why?
|
| Thrombolytic Therapy | 1 | 1994 | 2106 | 0.020 |
Why?
|
| Hospitals, Special | 1 | 1985 | 90 | 0.010 |
Why?
|
| Delphi Technique | 1 | 2008 | 818 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2007 | 13625 | 0.010 |
Why?
|
| Hospitals, Veterans | 1 | 1987 | 398 | 0.010 |
Why?
|
| Clinical Protocols | 1 | 1990 | 1438 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 1990 | 15726 | 0.010 |
Why?
|
| Knee Prosthesis | 1 | 1987 | 393 | 0.010 |
Why?
|
| Death, Sudden | 1 | 1986 | 302 | 0.010 |
Why?
|
| Recurrence | 3 | 2000 | 8465 | 0.010 |
Why?
|
| Decision Support Techniques | 1 | 1994 | 1999 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 1999 | 14648 | 0.010 |
Why?
|
| Sexual Behavior | 1 | 1993 | 2086 | 0.010 |
Why?
|
| Comprehension | 1 | 1989 | 613 | 0.010 |
Why?
|
| Sickness Impact Profile | 1 | 2004 | 298 | 0.010 |
Why?
|
| Educational Status | 1 | 1990 | 2512 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 1997 | 12526 | 0.010 |
Why?
|
| Education, Continuing | 1 | 2003 | 114 | 0.010 |
Why?
|
| Blood Pressure Determination | 1 | 1986 | 641 | 0.010 |
Why?
|
| Antiviral Agents | 1 | 1995 | 3062 | 0.010 |
Why?
|
| Organizational Case Studies | 1 | 2003 | 301 | 0.010 |
Why?
|
| Self-Assessment | 1 | 1984 | 393 | 0.010 |
Why?
|
| Angina Pectoris | 1 | 1986 | 970 | 0.010 |
Why?
|
| Research | 1 | 1990 | 1972 | 0.010 |
Why?
|
| Fellowships and Scholarships | 1 | 1990 | 1116 | 0.010 |
Why?
|
| Insurance Benefits | 1 | 2003 | 191 | 0.010 |
Why?
|
| Efficiency | 1 | 1985 | 477 | 0.010 |
Why?
|
| Women's Health | 1 | 1991 | 2057 | 0.010 |
Why?
|
| Health Behavior | 1 | 1993 | 2619 | 0.010 |
Why?
|
| Documentation | 1 | 2008 | 885 | 0.010 |
Why?
|
| Hip Prosthesis | 1 | 1987 | 917 | 0.010 |
Why?
|
| Prednisone | 1 | 1986 | 1563 | 0.010 |
Why?
|
| Methylphenidate | 1 | 2005 | 483 | 0.010 |
Why?
|
| Germany | 2 | 1993 | 873 | 0.010 |
Why?
|
| Periodicals as Topic | 1 | 1992 | 1469 | 0.010 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2006 | 1192 | 0.010 |
Why?
|
| Canada | 3 | 1993 | 2124 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 1990 | 2694 | 0.010 |
Why?
|
| Prognosis | 2 | 2000 | 29559 | 0.010 |
Why?
|
| Emotions | 2 | 1989 | 2731 | 0.010 |
Why?
|
| International Cooperation | 1 | 2006 | 1435 | 0.010 |
Why?
|
| Emergencies | 1 | 1986 | 1217 | 0.010 |
Why?
|
| Models, Econometric | 1 | 2000 | 216 | 0.010 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2003 | 385 | 0.010 |
Why?
|
| Pregnancy Complications | 1 | 1993 | 2938 | 0.010 |
Why?
|
| Therapeutic Irrigation | 1 | 2000 | 293 | 0.010 |
Why?
|
| Mental Health | 1 | 1993 | 3195 | 0.010 |
Why?
|
| Liver Transplantation | 1 | 1990 | 2311 | 0.010 |
Why?
|
| Gynecology | 1 | 1985 | 530 | 0.010 |
Why?
|
| Proton Pump Inhibitors | 1 | 2003 | 552 | 0.010 |
Why?
|
| Sodium Chloride | 1 | 2000 | 596 | 0.010 |
Why?
|
| Drug Approval | 1 | 2005 | 815 | 0.010 |
Why?
|
| Electrophysiology | 1 | 2000 | 1265 | 0.010 |
Why?
|
| Cerebral Veins | 1 | 1998 | 154 | 0.010 |
Why?
|
| Consensus | 1 | 2006 | 3091 | 0.010 |
Why?
|
| Cold Temperature | 1 | 2000 | 777 | 0.010 |
Why?
|
| Central Nervous System Stimulants | 1 | 2005 | 1169 | 0.010 |
Why?
|
| Cerebral Arteries | 1 | 1998 | 490 | 0.010 |
Why?
|
| Mozambique | 1 | 1995 | 55 | 0.010 |
Why?
|
| Arteriosclerosis | 1 | 2000 | 1052 | 0.010 |
Why?
|
| Patient Care Team | 1 | 1987 | 2509 | 0.010 |
Why?
|
| Focus Groups | 1 | 2000 | 1367 | 0.010 |
Why?
|
| Cognition | 2 | 1989 | 6939 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 1990 | 8050 | 0.010 |
Why?
|
| Amputation, Traumatic | 1 | 1995 | 136 | 0.010 |
Why?
|
| Streptokinase | 1 | 1994 | 187 | 0.010 |
Why?
|
| Radiography | 1 | 1984 | 6964 | 0.010 |
Why?
|
| Diabetes Complications | 1 | 2000 | 1342 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2006 | 8530 | 0.010 |
Why?
|
| Cerebral Angiography | 1 | 1998 | 1265 | 0.010 |
Why?
|
| Sick Role | 1 | 1993 | 230 | 0.010 |
Why?
|
| Health Services Administration | 1 | 1993 | 63 | 0.010 |
Why?
|
| Echocardiography | 1 | 1985 | 4970 | 0.010 |
Why?
|
| Calcium Channel Blockers | 1 | 1994 | 690 | 0.010 |
Why?
|
| Communication | 1 | 1985 | 3846 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 1990 | 418 | 0.010 |
Why?
|
| Urban Population | 1 | 1998 | 2015 | 0.010 |
Why?
|
| Job Satisfaction | 1 | 1993 | 535 | 0.010 |
Why?
|
| Blood Pressure | 1 | 1985 | 8520 | 0.010 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2003 | 3329 | 0.000 |
Why?
|
| Waiting Lists | 1 | 1993 | 749 | 0.000 |
Why?
|
| Tissue Plasminogen Activator | 1 | 1994 | 1188 | 0.000 |
Why?
|
| Cerebrovascular Circulation | 1 | 1998 | 2725 | 0.000 |
Why?
|
| Stroke Volume | 1 | 2000 | 5496 | 0.000 |
Why?
|
| Obesity | 1 | 1987 | 12896 | 0.000 |
Why?
|
| Rabbits | 1 | 1990 | 4772 | 0.000 |
Why?
|
| Heart Defects, Congenital | 1 | 2000 | 4663 | 0.000 |
Why?
|
| Smoking | 1 | 2000 | 9066 | 0.000 |
Why?
|
| Fetal Death | 1 | 1984 | 430 | 0.000 |
Why?
|
| Transfection | 1 | 1990 | 5781 | 0.000 |
Why?
|
| Reoperation | 1 | 1992 | 4286 | 0.000 |
Why?
|
| Psychometrics | 1 | 1991 | 3046 | 0.000 |
Why?
|
| Leukocyte Count | 1 | 1986 | 1599 | 0.000 |
Why?
|
| Antigens, Viral | 1 | 1986 | 980 | 0.000 |
Why?
|
| Wales | 1 | 1981 | 86 | 0.000 |
Why?
|
| Herpesvirus 4, Human | 1 | 1986 | 1074 | 0.000 |
Why?
|
| Infant Mortality | 1 | 1984 | 752 | 0.000 |
Why?
|
| Base Sequence | 1 | 1990 | 12442 | 0.000 |
Why?
|
| Lymphocytes | 1 | 1986 | 2601 | 0.000 |
Why?
|
| Molecular Sequence Data | 1 | 1990 | 17611 | 0.000 |
Why?
|
| Curriculum | 1 | 1990 | 3710 | 0.000 |
Why?
|
| Cells, Cultured | 1 | 1990 | 18937 | 0.000 |
Why?
|
| Liver | 1 | 1990 | 7514 | 0.000 |
Why?
|
| Antibodies, Viral | 1 | 1986 | 3143 | 0.000 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 1991 | 10329 | 0.000 |
Why?
|
| Animals | 1 | 1990 | 167531 | 0.000 |
Why?
|